Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Nasal Spreader Grafts: A Comparison of Medpor to Autologous Tissue Reconstruction

Reiffel, Alyssa J. MD*; Cross, Kevin J. MD; Spinelli, Henry M. MD

doi: 10.1097/SAP.0b013e3181d3ef8e
Aesthetic Surgery

Reconstruction of the damaged nasal vault is challenging. Limited available autologous tissue has lead surgeons to pursue alloplastic alternatives. A retrospective review comparing 18 patients who underwent secondary rhinoplasty with internal nasal valve reconstruction with spreader graft (SG) implants using either autologous tissue or high-density porous polyethylene (Medpor) was performed. All underwent bilateral SG reconstruction of the internal nasal valve with Medpor (10 cases) or autologous cartilage (8 cases). Mean follow-up was 26 months for the autologous group and 29 months for the Medpor group. Functional performance and aesthetic results were identical. Complications were few: 1 case of unilateral infection in the Medpor group treated with partial excision, and 1 case of erythema at the auricular donor site for the autologous tissue group. For patients who have exhausted autologous tissue options or are unwilling to tolerate potential donor-site morbidity, the Medpor SG is an appropriate option that allows for excellent aesthetic and functional results that remains stable over time.

From the *Department of Surgery, and †Division of Plastic Surgery, Department of Surgery, New York Presbyterian Hospital, Weill-Cornell Medical Center, New York, NY.

Received August 12, 2009, and accepted for publication, after revision, January 10, 2010.

None of the authors hold any commercial association or financial disclosures that might pose or create a conflict of interest with the information presented in this article. This research was not supported by outside funding.

Reprints: Henry M. Spinelli, MD, FACS, Weill Medical College of Cornell University, 875 Fifth Avenue, New York, NY 10065. E-mail:

© 2011 Lippincott Williams & Wilkins, Inc.